# 119-hr-10088: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes.

119-hr-10088, To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes., is a 119th Congress bill sponsored by Rep. Foushee, Valerie P. [D-NC-4] (D-NC); status introduced (as of 2026-08-22).

- Canonical: https://policyrisk.com/legislation/119-hr-10088
- As of: 2026-08-22
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-10088
- Congress: 119
- Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes.
- Status: introduced
- Introduced: 2026-08-13
- Sponsor: Rep. Foushee, Valerie P. [D-NC-4] (D-NC)
- Cosponsors: 0
- Policy area: Health
- Touches household money: no
- Last recorded action: 2026-08-22

## Summary

**This bill would direct HHS to study whether expanding the safe, effective reprocessing of single-use medical devices is practical.** The study would prioritize patient safety and infection prevention while weighing clinical, operational, financial, environmental, and legal factors. - Patients: The study would prioritize infection prevention and examine clinical outcomes and device performance for reprocessed items. - Hospitals and sterile processing staff: It would assess operational feasibility, including sterile processing capacity, staffing, equipment, chain of custody, tracking, and quality assurance. - Third-party reprocessors and in-house programs: The study would compare roles, opportunities, and barriers for qualified third-party reprocessors versus in-house hospital reprocessing. - Costs and environment: It would evaluate waste reduction, cost savings, and full lifecycle financial and environmental impacts of reprocessing. - Liability and accountability: The study would analyze legal and liability issues if a reprocessed device fails or causes patient harm. - Reporting and guidance: HHS would be asked to report to Congress within one year of enactment listing devices suitable for reprocessing and recommending programs, technologies, and infection control measures.

## Related bills

- 119-hr-4669: FEMA Act of 2025
- 119-hr-7977: Energy Bills Relief Act
- 119-hr-7481: Department of Homeland Security Appropriations Act, 2026
- 119-hr-7973: Momnibus Act
- 119-hr-5089: Weather Act Reauthorization Act of 2025
- 119-hr-7273: NASA Reauthorization Act of 2026

## Sources
- [119-hr-10088 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/10088)

## Related
- [119-hr-4669: FEMA Act of 2025](https://policyrisk.com/legislation/119-hr-4669)
- [119-hr-7977: Energy Bills Relief Act](https://policyrisk.com/legislation/119-hr-7977)
- [119-hr-7481: Department of Homeland Security Appropriations Act, 2026](https://policyrisk.com/legislation/119-hr-7481)
- [119-hr-7973: Momnibus Act](https://policyrisk.com/legislation/119-hr-7973)
- [119-hr-5089: Weather Act Reauthorization Act of 2025](https://policyrisk.com/legislation/119-hr-5089)
- [119-hr-7273: NASA Reauthorization Act of 2026](https://policyrisk.com/legislation/119-hr-7273)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-10088 (as of 2026-08-22).